SBK Financial’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
SBK Financial's LGND Position: Q2 2026 in Review
SBK Financial sold out of Ligand Pharmaceuticals (LGND) in Q2 2026, closing a stake of 27 shares — an estimated $5.39K sold.
SBK Financial first reported a position in LGND in Q1 2026 and held it in 1 quarter. The position peaked at $5.39K in Q1 2026. 419 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- SBK Financial reported no remaining Ligand Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- SBK Financial sold 27 Ligand Pharmaceuticals shares in Q2 2026, an estimated $5.39K.
- SBK Financial first reported a position in Ligand Pharmaceuticals in Q1 2026 and held it in 1 quarter.
- SBK Financial's Ligand Pharmaceuticals position peaked at $5.39K in Q1 2026.
- 419 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on SBK Financial's 13F filing for Q2 2026, filed 2 Nov 2026.